Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer-Reference-Cited by-同舟云学术

Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer

Published:2012-01-17 Issue:5 Volume:226 Page:746-755
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Furlong Fiona,Fitzpatrick Patricia,O'Toole Sharon,Phelan Sine,McGrogan Barbara,Maguire Aoife,O'Grady Anthony,Gallagher Michael,Prencipe Maria,McGoldrick Aloysius,McGettigan Paul,Brennan Donal,Sheils Orla,Martin Cara,W Kay Elaine,O'Leary John,McCann Amanda

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference42 articles.

1. Ovarian cancer: an overview;Roett;Am Fam Physician,2009

2. Ovarian cancer;Cho;Annu Rev Pathol,2009

3. Ovarian cancer: can we reverse drug resistance?;Tan;Adv Exp Med Biol,2008

4. Taxanes, microtubules and chemoresistant breast cancer;McGrogan;Biochim Biophys Acta,2008

5. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function;Iwanaga;J Biol Chem,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options;Cells;2024-05-04

2. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer;Pathology - Research and Practice;2024-01

3. New Keys for the Old Locks: Utilizing Spindle Assembly Checkpoints as a Target for Cancer Therapy;2024

4. Targeting TRIP13 for overcoming anticancer drug resistance (Review);Oncology Reports;2023-09-29

5. MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex;Oncogene;2023-09-26